Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP*

Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P generation earlier this year at the Centre Hospitalier de l'Université de Montréal. The patient received an Amvia Sky HF-T QP triple chamber pacemaker device. The first implant follows the full market release of BIOTRONIK’s newest family of pacemaker and CRT-P devices, featuring patient-centric technologies for better patient care and simplified workflows.

“The Amvia Sky HF-T QP offers a significant number of advanced features, making it the most complete CRT-P on the market including streamlined care pathways,” commented Dr. Mansour after the procedure. 

The Amvia Sky system offers the following new features:

• Industry-leading choice with 20 left ventricular (LV) pacing polarities, automatically tested in less than 2.5 minutes. 
• CRT AutoAdapt which automatically adjusts to changes in the patient’s condition for a more personalized response. 
• Enhanced Closed Loop Stimulation (CLS) rate adaptation technology.
• Atrial arrhythmia management tools, including atrial antitachycardia pacing (ATP).
• Streamlined Care Pathways.
• Next-generation MRI access with MRI Guard 24/7.

“BIOTRONIK is dedicated to continually improving our technologies, and the Amvia Sky family is a great example of this commitment,” said Angela McGonigle, Country Director BIOTRONIK Canada. “Our latest family of pacemaker and CRT-P devices offers advanced features for optimized therapy and improved workflow simplification for Allied Health Professionals.” 

References:

1.* BIOTRONIK Amvia Sky technical manual, Medtronic Azure XT DR MRI SureScan™ manual; Boston Scientific Accolade MRI™ technical manual; Abbott Assurity MRI™ user’s manual; MicroPort Alizea™ implant manual. 

2. Garcia-Fernández FJ, Asensi JO, Romero R, et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE). Eur Heart J. 2019; 40(23): 1837–1846.

3. Data on file.

4. Mullane S, Michaelis K, Henrickson C, et al. Utilization and programming of an automatic MRI recognition feature for cardiac rhythm management devices. Heart Rhythm. O2. 2021; 2: 132–137.